Documents to download

Human Immunodeficiency Virus (HIV) attacks specific cells of the immune system, weakening the body’s ability to fight infections and disease. If left untreated, the immune system can become severely damaged, often leading to the development of acquired immune deficiency syndrome (AIDS). In 2014, an estimated 103,700 people were living with HIV in the United Kingdom. However, at present, there is currently no vaccine for HIV, with anti-retroviral drugs used in many countries both to prevent and treat the virus. In the United Kingdom, a course of drugs—known as post-exposure prophylaxis (PEP)—is given to individuals who have already tested positive for the virus, whilst preventative treatment—known as pre-exposure prophylaxis (PrEP)—for individuals at-risk of contracting the virus, is not currently provided to patients outside of a clinical trials environment.

Documents to download

Related posts

  • The Government has announced that the England-wide Covid-19 restrictions commonly referred to as ‘lockdown 2’ will not be renewed past 2 December 2020. The restrictions are to be replaced with a revised tier structure for England similar to the one in place before the second lockdown. The revised tiers form part of the Government’s Winter Plan, which was announced on 23 November 2020.

  • Medicinal and agrochemical products can be granted a Supplementary Protection Certificate, an intellectual property right associated with patents, to provide up to five years of additional rights and protections once their patents have expired. In order to apply for an SPC, a product must receive approval to be sold on the UK market. Under the Northern Ireland/Ireland Protocol, products to be sold in Northern Ireland must obtain approval under EU law, whilst products to be sold in the rest of the UK will obtain approval under UK law. Currently, this marketing authorisation is only given on a UK-wide basis. This regulation amends the market authorisation process to enable authorisations to be granted for the Northern Ireland market only and for the Great Britain market only.

  • There is currently a system for mutual recognition of health and social care qualifications within and between European Economic Area states and Switzerland. The UK has passed legislation amending its provisions in this area to take account of its exit from the EU. In recent agreements with Switzerland and the European Free Trade Area states, the UK committed to conditions for these countries which go further than the legislation that has already been passed. The European Qualifications (Health and Social Care Professions) (EFTA States) (Amendment etc.) (EU Exit) Regulations 2020 would implement these commitments.